SPY295.44+0.56 0.19%
DIA244.88-0.14 -0.06%
IXIC9,324.59+39.71 0.43%

RBC Capital Downgrades Gilead Sciences to Outperform, Announces $86 Price Target

RBC Capital analyst Brian Abrahams downgrades Gilead Sciences (NASDAQ:GILD) from Top Pick to Outperform and announces $86 price target.

Benzinga · 03/09/2020 10:46

RBC Capital analyst Brian Abrahams downgrades Gilead Sciences (NASDAQ:GILD) from Top Pick to Outperform and announces $86 price target.